8-K Announcements
6May 6, 2026·SEC
May 4, 2026·SEC
Apr 15, 2026·SEC
Ingevity Corporation (NGVT) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's precarious financial position is highlighted by a debt-to-equity ratio of 30.96 and a consistent pattern of negative net income, which suggests significant long-term solvency risks.
Ingevity Corporation (NGVT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Ingevity Corporation (NGVT) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $1.15vs $0.84+36.9% | $258Mvs $255M+1.3% |
| Q1 2026 | Feb 25, 2026 | $0.58vs $0.67-12.8% | $255Mvs $257M-0.8% |
| Q4 2025 | Nov 5, 2025 | $1.31vs $0.68+92.6% | $333Mvs $257M+29.5% |
| Q3 2025 | Aug 4, 2025 | $1.39vs $1.02+36.3% | $365Mvs $372M-1.9% |
Key metrics vs top competitors for Ingevity Corporation (NGVT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $77.12 | $2.72B | -16.73 | -16.98% | -14.31% | -148.6% | — | |
| $63.25 | $3.45B | 23.00 | -2.67% | 5.29% | 9.16% | — | |
| $82.63 | $2.04B | 17.69 | -3.65% | 6.38% | 8.64% | — | |
| $160.63 | $2.78B | -1147.36 | 2.66% | 0.22% | 0.31% | — | |
| $93.40 | $4.88B | 15.52 | -7.04% | 7.97% | 16.75% | — | |
| $20.27 | $546.46M | 11.26 | 0.31% | 0.67% | 1.28% | — |
Ingevity Corporation (NGVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Ingevity Corporation (NGVT) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 6, 2026·SEC
May 4, 2026·SEC
Apr 15, 2026·SEC
Get notified when NGVT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Ingevity Corporation (NGVT) stock FAQ — growth, dividends, profitability & financials explained
Ingevity Corporation (NGVT) reported $1.21B in revenue for fiscal year 2025. This represents a 24% increase from $980.0M in 2013.
Ingevity Corporation (NGVT) saw revenue decline by 17.0% over the past year.
Ingevity Corporation (NGVT) reported a net loss of $127.8M for fiscal year 2025.
Ingevity Corporation (NGVT) has a return on equity (ROE) of -148.6%. Negative ROE indicates the company is unprofitable.
Ingevity Corporation (NGVT) generated $245.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.